Publication | Open Access

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

Second-line TreatmentMetastatic Urothelial CancerUrologyCombination ChemotherapyGenitourinary CancerMedicinePharmacotherapyCancer TreatmentOncology